Overview
We’re building the future of medical dermatology by focusing on unmet patient needs and giving people the space to think independently, take ownership and make an impact that matters. Our purpose is simple: to transform patients’ lives by addressing real needs. We work with care, act with courage, keep things simple and focus our innovation where it makes a difference. Recognised as a Top Employer in Spain since 2008 and in Germany since 2025, we continue to invest in an environment where people can grow and move forward. If you care differently, you belong here.
Mission
To lead and execute the Integral Medical Affairs strategy for AD, with a strong focus on launch excellence, early lifecycle value generation and innovation in evidence development, ensuring high-quality scientific execution and effective global-to-local implementation under the direction and governance of the VP Global Medical Affairs, Biologics. The role is accountable for asset-level excellence for a growth-stage biologic, contributing to portfolio priorities through disciplined execution, learning agenda generation and differentiation.
Responsibilities
* Asset-Level Medical Strategy Execution: Develop and execute the Global Medical Affairs plan for Ebglyss, aligned with biologics portfolio strategy and VP guidance, with particular focus on launch and early post-launch phases. Translate portfolio-level priorities into agile, executable asset plans supporting differentiation and uptake. Ensure medical activities are compliant with global governance while enabling fast, high-impact execution.
* Scientific & Evidence Excellence: Execute asset-specific components of Integrated Evidence Generation Planning (IEGP), focusing on evidence gaps relevant to early positioning and stakeholder decision making. Contribute to innovative study design, publications and congress strategy in alignment with portfolio-level evidence direction. Drive high-quality scientific exchange with global and regional K
#J-18808-Ljbffr